About Interventional Cardiology Devices
Interventional cardiology devices are used to treat cardiovascular diseases using non-surgical procedures by the board-certified cardiologists. The cardiac inserts the catheter in the upper leg into the femoral artery, most of the process is done through heart veins and arteries which doesn't require any large incisions in the body. The technological advancement in the healthcare industry has been boosting the market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Interventional Cardiology Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Boston Scientific (United States), Medtronic (Ireland), Abbott (United States), Volcano Corporation (United States), Philips Healthcare (Netherlands), Access Closure (United States), Terumo Corporation (Japan), Johnson & Johnson (United States), B. Braun Melsungen (Germany) and Edwards Lifesciences (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Interventional Cardiology Devices market by Type (Catheters, Coronary Stents, Percutaneous Transluminal Coronary Angioplasty Balloons(PTCA), Percutaneous Transluminal Coronary Angioplasty Guidewire (PTCA) and Others), Application (Hospital, Clinic, Catheterization Labs and Others) and Region.
On the basis of geography, the market of Interventional Cardiology Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material, the sub-segment i.e. Polymers (PTFE will boost the Interventional Cardiology Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Awareness about Heart Diseases for Checkups and Increasing Government Investment in the Healthcare Industry
Market Growth Drivers:
Growing Cardiac Diseases in Aged People and Technological advancement in the Medical Industry
Challenges:
High Manufacturing Cost of Interventional Cardiology Devices might Hinder the Growth
Restraints:
Stringent Regulatory norms Regarding Healthcare Devices and Risk of Harmful Radiations from the Devices
Opportunities:
Technology Advancement in Interventional Cardiology Devices for providing Efficiency and Reliability and Continuous Research and Development for Drugs
Market Leaders and their expansionary development strategies
On 13th June 2019, Terumo Corporation announced its strategic partnership with Orchestra BioMed Inc. which is the biomedical company for providing effective solutions in procedure-based medicine that has secured the global development and commercialization rights to Virtue Sirolimus-Eluting Balloon (SEB) for transdermal coronary interventions.
In February 2024, Royal Philips has launched the new Azurion neuro biplane interventional system, a significant enhancement to its image-guided therapy system. The system is designed to streamline neurovascular procedures, aiding care teams in making quicker decisions, treating more patients and achieving better outcomes.
Key Target Audience
Interventional Cardiology Devices Manufacturers, Interventional Cardiology Devices International Traders, Interventional Cardiology Devices Distributors and Suppliers, Research and Development Institutes, Potential Investors, Hospitals, Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.